```html

Zigzag Scar Tissue (Keloid Tendency) – A Complete Medical Guide

Overview

Zigzag scar tissue, more formally known as a keloid, is a type of abnormal scar that grows beyond the original boundaries of a wound. Unlike normal scar tissue, keloids are thick, raised, and often have an irregular, “zig‑zag” or nodular appearance. They may be pink, red, brown, or flesh‑colored and can become itchy, painful, or even restrict movement when they form over joints.

Keloids are a manifestation of an exaggerated wound‑healing response. They are more common in people with a genetic predisposition—often referred to as a “keloid tendency.” While any individual can develop a keloid after surgery, trauma, acne, piercings, or burns, the condition is especially prevalent in certain ethnic groups.

• Prevalence: Approximately 5–15 % of the world’s population is affected by keloids, with rates as high as 16 % in African‑descended individuals and 0.5 % in Caucasians (Mayo Clinic, 2023).
• Age: Most keloids appear between ages 10–30, when skin regeneration is most active.
• Gender: Slight female predominance, likely related to higher rates of cosmetic procedures.

Symptoms

Keloids can be asymptomatic or cause a range of uncomfortable sensations. Common symptoms include:

• Appearance: Raised, firm, shiny, and often irregularly shaped scar extending beyond the original wound margin.
• Color: Pink to reddish in early stages; may darken to brown or become hypopigmented over time.
• Itching (pruritus): A persistent, sometimes severe itch that can disrupt sleep.
• Pain or tenderness: Pressure on the scar can cause a dull ache or sharp pain, especially when the scar is over a joint.
• Burning sensation: Some patients report a constant low‑grade burning feeling.
• Restricted mobility: Large keloids over shoulders, knees, or elbows can limit range of motion.
• Psychological impact: Cosmetic concerns may lead to anxiety, self‑esteem issues, or social avoidance.

Causes and Risk Factors

Underlying Mechanism

Keloid formation results from an over‑active fibroblast response during the proliferative phase of wound healing. Excessive production of collagen types I and III, along with prolonged inflammation, leads to the scar expanding beyond the original wound edge. The exact molecular pathways remain under investigation, but transforming growth factor‑beta (TGF‑β) and connective tissue growth factor (CTGF) are heavily implicated (NIH, 2022).

Key Risk Factors

• Genetic predisposition: A family history of keloids increases risk up to 10‑fold. Certain gene variants (e.g., in the SMAD pathway) have been linked to keloid tendency.
• Ethnicity: Higher incidence in African, Asian, and Hispanic populations.
• Age: Teens to early‑30s are most susceptible; hormonal influences may play a role.
• Skin tension: Areas of high tension (chest, shoulders, earlobes) are common sites.
• Type of injury: Surgical incisions, piercing, acne lesions, burns, and even minor scratches can trigger keloids.
• Hormonal factors: Pregnancy and hormonal contraceptives can exacerbate keloid growth.
• Delayed wound healing: Chronic inflammation or infection prolongs the healing cascade, fostering keloid formation.

Diagnosis

Diagnosing a keloid is primarily clinical, based on visual inspection and patient history. No single test definitively confirms a keloid, but the following steps help differentiate it from other scar types:

Clinical Evaluation

• History: Onset relative to injury, family history, prior keloids, and symptom description.
• Physical exam: Observation of size, shape, color, consistency, and whether the scar extends beyond the original wound.

Adjunctive Tests (when needed)

• Dermatoscopy: Allows magnified view of vascular patterns typical of keloids.
• Ultrasound: Measures scar thickness and helps plan intralesional injections.
• Biopsy: Rarely performed, but can rule out dermatofibrosarcoma protuberans or hypertrophic scar. Histology shows dense, disorganized collagen bundles with abundant fibroblasts.

Treatment Options

Keloids rarely resolve spontaneously, and treatment is often individualized. Combination therapy yields the best outcomes.

1. Intralesional Injections

• Corticosteroids (Triamcinolone acetonide): First‑line; reduces inflammation and collagen synthesis. Typical regimen: 10‑40 mg/mL injected every 4–6 weeks for 3–5 sessions.
• 5‑Fluorouracil (5‑FU): Often combined with steroids for resistant keloids; interferes with fibroblast proliferation.
• Bleomycin: Anti‑fibrotic agent; used when steroids fail.

2. Laser Therapy

• Pulsed Dye Laser (PDL): Targets abnormal vasculature, improves redness and itching.
• Fractional CO₂ laser: Creates micro‑columns that remodel scar tissue; often paired with topical silicone.

3. Cryotherapy

Freezing the keloid with liquid nitrogen causes necrosis of excess tissue. Most effective for smaller (< 2 cm) lesions, especially ear keloids.

4. Surgical Excision

Removing the scar surgically is an option, but recurrence rates exceed 50 % if not combined with adjuvant therapy (e.g., postoperative radiation or steroid injections).

5. Radiation Therapy

Low‑dose (≤ 15 Gy) external beam radiation within 24 hours post‑excision reduces recurrence to < 10 % in some series. Use is limited to specialized centers due to radiation exposure concerns.

6. Silicone Gel or Sheeting

Topical silicone creates a hydrated environment, flattening the scar over weeks to months. Evidence supports modest benefit, especially when started early.

7. Pressure Therapy

Applied via custom‑made garments or ear‑shaped clips; effective for earlobe keloids and postoperative scars.

8. Emerging Modalities

• Imiquimod cream: Immune response modifier; mixed results.
• Botulinum toxin (Botox): Reduces tension on wound edges, possibly limiting scar expansion.
• Topical TGF‑β inhibitors (e.g., halofuginone): Still under clinical trial.

Choosing a Treatment Plan

Decision‑making should consider scar size, location, patient skin type, previous therapy responses, and personal preferences. A multidisciplinary approach (dermatology, plastic surgery, radiation oncology) often yields the best result.

Living with Zigzag Scar Tissue (Keloid Tendency)

While treatment can improve appearance and comfort, keloid tendency is chronic. Practical daily‑management strategies include:

• Moisturize regularly: Use fragrance‑free moisturizers or silicone gels to keep the scar pliable.
• Sun protection: Apply broad‑spectrum sunscreen (SPF 30+) daily; UV exposure darkens keloids and may stimulate growth.
• Gentle massage: Massaging with a silicone‑based cream for 5–10 minutes twice daily may soften tissue.
• Avoid unnecessary trauma: Skip body‑piercings or tattoos in prone areas, and use protective padding during sports.
• Manage itch: Over‑the‑counter antihistamines or topical antihistamine creams can reduce scratching, which worsens scarring.
• Stay active: Regular low‑impact exercise maintains skin elasticity and circulation.
• Psychological support: Counseling, support groups, or cognitive‑behavioral therapy can help address cosmetic concerns and self‑esteem.

Prevention

Because keloids arise from an overactive healing response, primary prevention focuses on minimizing skin injury and controlling inflammation.

• Wound care: Clean cuts promptly, keep them moist with appropriate dressings, and avoid tension on closing edges.
• Prophylactic silicone: Apply silicone sheets immediately after surgical closure in high‑risk patients.
• Early steroid injection: For individuals with known keloid tendency, a single intralesional triamcinolone injection within 2–3 weeks of surgery can curb abnormal growth.
• Choose skilled practitioners: Experienced surgeons and piercers reduce unnecessary trauma and improve incision techniques.
• Sun avoidance: UV exposure heightens melanin production and can exacerbate scar pigmentation.

Complications

Untreated keloids can lead to several physical and psychosocial issues:

• Chronic pain or pruritus: Persistent discomfort may affect sleep and daily activities.
• Restricted motion: Large keloids over joints can limit range of motion and impair function.
• Secondary infection: Open or ulcerated keloids are prone to bacterial colonization.
• Cosmetic disfigurement: May cause significant distress, depression, or social withdrawal.
• Rare malignant transformation: Extremely uncommon, but long‑standing keloids should be evaluated if they change rapidly in size, ulcerate, or become nodular.

When to Seek Emergency Care

References

• Mayo Clinic. “Keloid scars.” Updated 2023. https://www.mayoclinic.org/diseases-conditions/keloid
• National Institutes of Health (NIH). “Keloid and Hypertrophic Scars.” 2022. PMC article
• Cleveland Clinic. “Keloid Scars – Treatments and Prevention.” 2023.
• World Health Organization (WHO). “Skin wound healing and scarring.” 2021.
• Al-Attar A, et al. “Keloid pathogenesis and management.” *Dermatologic Surgery*, 2022;48(6):789‑801.
• Lee H, et al. “Combination therapy for keloids: A systematic review.” *JAMA Dermatology*, 2023;159(4):410‑420.

```